Ju‐Seog Lee

Active 2002–2026

Also published as
Ju-Seog Lee
119
Papers
21,055
Citations
83
h-index
117
i10-index

Citations

Citations per year for Ju‐Seog Lee1984: 1 citations1991: 1 citations2001: 1 citations2002: 3 citations2003: 2 citations2004: 12 citations2005: 24 citations2006: 49 citations2007: 76 citations2008: 123 citations2009: 105 citations2010: 210 citations2011: 220 citations2012: 259 citations2013: 263 citations2014: 327 citations2015: 342 citations2016: 300 citations2017: 348 citations2018: 357 citations2019: 1,042 citations2020: 1,067 citations2021: 972 citations2022: 709 citations2023: 505 citations2024: 666 citations2025: 331 citations2026: 6 citations1985–1990: no citations, so these years are not shown1992–2000: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,913 citing papers, 25.4% of this breakdownChina: 2,486 citing papers, 21.7% of this breakdownGermany: 539 citing papers, 4.7% of this breakdownItaly: 483 citing papers, 4.2% of this breakdownUnited Kingdom: 474 citing papers, 4.1% of this breakdownSouth Korea: 445 citing papers, 3.9% of this breakdownJapan: 424 citing papers, 3.7% of this breakdownFrance: 361 citing papers, 3.1% of this breakdownSpain: 332 citing papers, 2.9% of this breakdownCanada: 251 citing papers, 2.2% of this breakdownAustralia: 228 citing papers, 2% of this breakdownIndia: 177 citing papers, 1.5% of this breakdown
0%25.4%Other 20.6%

Fields

  • Biochemistry, Genetics and Molecular Biology48.2%
  • Medicine44.2%
  • Immunology and Microbiology3.9%
  • Neuroscience1.2%
  • Computer Science0.5%
  • Engineering0.4%
  • Other1.6%

Topics

  • Epigenetics and DNA Methylation3.3%
  • Cancer Cells and Metastasis3.2%
  • Ferroptosis and cancer prognosis2.9%
  • Hippo pathway signaling and YAP/TAZ2.8%
  • RNA modifications and cancer2.7%
  • Cancer Immunotherapy and Biomarkers2.7%
  • Other82.4%

Coauthors

All papers

Open in search
  1. A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early-Stage Hepatocellular Carcinoma Patients

    Authors: , , , , , , , , , , - Cancer Research 2010 cited by 1,093

  2. Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project

    Authors: , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2017 cited by 479

  3. Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeeyun Lee, Won Ki Kang, Sung Hoon Kim, Sung Hoon Noh, Gordon B. Mills, Seon‐Young Kim, Jaffer A. Ajani, Ju‐Seog Lee, Seon‐Young Kim, Jaffer A. Ajani, Ju‐Seog Lee, Ju‐Seog Lee - Nature Communications 2018 cited by 464

  4. Androgen receptor inhibitor–induced “BRCAness” and PARP inhibition are synthetically lethal for castration-resistant prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Science Signaling 2017 cited by 304

  5. Platelets reduce anoikis and promote metastasis by activating YAP1 signaling

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2017 cited by 278

  6. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling

    Authors: , , , , , , , , - Hepatology 2004 cited by 920

  7. Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Randy L. Johnson, George A. Călin, Guang Peng, Ju‐Seog Lee, Samir Hanash, P. Andrew Futreal, Zhenning Wang, Linghua Wang, Jaffer A. Ajani - Gut 2019 cited by 176

  8. Large conserved domains of low DNA methylation maintained by Dnmt3a

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2013 cited by 326

  9. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver

    Authors: , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2010 cited by 723

  10. CD38-Expressing Myeloid-Derived Suppressor Cells Promote Tumor Growth in a Murine Model of Esophageal Cancer

    Authors: , , , , , , , , , , - Cancer Research 2015 cited by 167

  11. Ubiquitous Activation of Ras and Jak/Stat Pathways in Human HCC

    Authors: , , , , , , , - Gastroenterology 2006 cited by 728

  12. YAP1 mediates gastric adenocarcinoma peritoneal metastases that are attenuated by YAP1 inhibition

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Gut 2020 cited by 104

  13. Stearoyl-CoA Desaturase Promotes Liver Fibrosis and Tumor Development in Mice via a Wnt Positive-Signaling Loop by Stabilization of Low-Density Lipoprotein-Receptor-Related Proteins 5 and 6

    Authors: , , , , , , , , , , , , , , , , , , - Gastroenterology 2017 cited by 165

  14. Yes‐associated protein 1 and transcriptional coactivator with PDZ‐binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , - Hepatology 2015 cited by 162

  15. Intrinsic Subtypes of Gastric Cancer, Based on Gene Expression Pattern, Predict Survival and Respond Differently to Chemotherapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2011 cited by 366

  16. Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Research 2009 cited by 857

  17. Hematogenous Metastasis of Ovarian Cancer: Rethinking Mode of Spread

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Isaiah J. Fidler, Anil K. Sood - Cancer Cell 2014 cited by 323

  18. Genome-wide transcriptome profiling of homologous recombination DNA repair

    Authors: , , , , , , , , , , , , , , - Nature Communications 2014 cited by 228

  19. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells

    Authors: , , , , , , , , , , , , - Nature Medicine 2006 cited by 944

  20. Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features

    Authors: , , , , , , , , - Journal of Hepatology 2020 cited by 64

  21. Regulation of Tumor Angiogenesis by EZH2

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Emir Baki Denkbaş, Jae Yun Lim, Ju‐Seog Lee, Vikas Kundra, Michael J. Birrer, Mien‐Chie Hung, Gabriel Lopez‐Berestein, Anil K. Sood - Cancer Cell 2010 cited by 402

  22. Significant Association of Oncogene YAP1 with Poor Prognosis and Cetuximab Resistance in Colorectal Cancer Patients

    Authors: , , , , , , , , , , - Clinical Cancer Research 2014 cited by 162

  23. Inactivation of Hippo Pathway Is Significantly Associated with Poor Prognosis in Hepatocellular Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2015 cited by 124

  24. Anti-inflammatory Roles of Glucocorticoids Are Mediated by Foxp3+ Regulatory T Cells via a miR-342-Dependent Mechanism

    Authors: , , , , , , , , , , , , , , - Immunity 2020 cited by 104